Peptide Sciences Tesamorelin: Tesamorelin is a small peptide and man-made form of GHRH (growth-hormone-releasing peptide). It is used to decrease excess fat in the stomach caused by taking anti-HIV drugs. Formally known in the research and science community as TH9507 this peptide controls the brain’s secretion of GHRF. The growth-hormone-releasing factor forces the production and distribution of growth hormones in the body. This increases metabolism, lowers abdominal fat, improves the body shape and energy levels.
All of this helps reduce abdominal fat in HIV-positive people with few side effects. In studies, Tesamorelin has shown to be better than using growth hormone on its own. However, the belly fat can return when the Tesamorelin dosage has been stopped. It does not affect the fat layer just below the skin of any other part of the body. Before doctors will prescribe Tesamorelin, it is often recommended that a CT scan of the abdomen be performed to confirm the presence of excess abdominal fat.
Tesamorelin Peptide Results
Tesamorelin has been shown to be effective in treating abnormal abdominal fat accumulation in the context of HIV infection and antiretroviral therapy. In further studies with Tesamorelin, it has shown to be effective in lowering the fat that accumulates in the liver and causes liver damage in people with HIV infection. This synthetic peptide, called Tesamorelin (trademark of Egrifta), is available as an injection solution. Recently, Tesamorelin has been the focus of research on its applicability for the treatment of non-alcoholic fatty liver disease (NAFLD) in people with HIV infection.
A Study with Tesamorelin Peptide Dosage
Tesamorelin reduces visceral adipose tissue in HIV-infected patients with abdominal lipo-hypertrophy. It can lower abdominal fat in all subjects. The peptide sciences Tesamorelin has had positive results in improving cognitive function in cognitively normal and slightly impaired adults in a placebo-controlled study. This study by researcher Dr. Laura D. Bakerhere discovered the following. The results of standard tests of executive function and verbal memory were significantly higher in participants receiving Tesamorelin (trademark Egrifta), a synthetic analog of growth hormone-releasing hormone (GHRH), in a 20-week study. Participants taking the drug in the study for 78 people also reported a greater subjective improvement in cognition compared with the placebo group.
A trial with healthy adults in the mid-2000s with GHRH (growth-hormone-releasing hormone) found small important improvements in cognitive test results. More current studies by the National Aging Institute discovered tests done on adults with mild cognitive impairment found Tesamorelin provided some positive protection among patients with cognitive impairment.
Tesamorelin can reduce lipodystrophy in individuals. Lipodystrophy is a condition people suffer where the location of body fat changes and accumulates in different areas such as the abdominal, stomach, and liver. This is visceral body fat. Often peptides such as Tesamorelin, Sermorelin, and GHRP-6 can encourage HGH production and therefore result in fat loss.
Possible Tesamorelin Benefits and Side effects
Tesamorelin’s benefits include an impressive reduction in belly fat and effectiveness in increasing growth hormone. Side effects logged with Tesamorelin are mostly irritation from the injection. Swelling and tingling in the fingers or hands. Tesamorelin can also cause high blood sugar and increase the risk of type 2 diabetes. In clinical trials, the best dosage that worked was tesamorelin 2mg once a day into the stomach.
Tesamorelin Peptide for sale
Tesamorelin is still classed as a research peptide and is still being extensively tested. So far it has shown to be effective in many areas of health issues. These special research chemicals are available for all research facilities. They are not for human consumption. For those in this industry Peptide Sciences Tesamorelin, 2mg is available HERE: Tesamorelin 2mg (10 Vial Kit) special offer